Gynecologic Cancer section

Gynecologic Cancer News and Features

Combination Estrogen/Continuous Progestin Reduces Postmenopausal Risk of Endometrial Cancer

Combination Estrogen/Continuous Progestin Reduces Postmenopausal Risk of Endometrial Cancer

Adding continuous progestin to estrogen lowers the risk of endometrial cancer in postmenopausal women, according to a new study.

Incidence of Undetected Cancer in Patients Undergoing Gynecologic Surgery for a Benign Condition Higher Than Estimated

Researchers in Massachusetts sought to determine how frequently cancer is diagnosed in women after undergoing gynecologic surgery for a problem believed to be benign.

Venlafaxine May Have Activity in Taxane-, Oxaliplatin-Induced Acute Neurotoxicity

Venlafaxine May Have Activity in Taxane-, Oxaliplatin-Induced Acute Neurotoxicity

Venlafaxine has a significant clinical activity against taxane-oxaliplatin-induced acute neurosensory toxicity in patients with cancer.

Timing of Chemotherapy Initiation May Affect Advanced Ovarian Cancer Survival

Timing of Chemotherapy Initiation May Affect Advanced Ovarian Cancer Survival

Survival for women with advanced ovarian cancer may be negatively impacted when chemotherapy is initiated more than 25 days after surgery.

Hormone replacement therapy safe, may be beneficial for women treated for ovarian cancer

Hormone replacement therapy safe, may be beneficial for women treated for ovarian cancer

Women with epithelial ovarian cancer, the most common type, can safely take hormone replacement therapy (HRT).

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs